Xponance, Inc. 9 Meters Biopharma, Inc. Transaction History

Xponance, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$0.26 - $0.64 $2,793 - $6,875	-10,743 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$0.52 - $1.0 $20 - $39	-39 Reduced 0.36%	10,743 $6,000
Q4 2021 Jan 31, 2022	BUY	$0.85 - $1.33 $207 - $324	244 Added 2.32%	10,782 $11,000
Q3 2021 Nov 05, 2021	SELL	$1.03 - $1.41 $1,128 - $1,545	-1,096 Reduced 9.42%	10,538 $14,000
Q2 2021 Aug 12, 2021	BUY	$1.04 - $1.5 $12,099 - $17,451	11,634 New	11,634 $13,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.